Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia.
about
Fundamentals of aerosol therapy in critical careSurfactant for pediatric acute lung injurySurfactant therapy for acute lung injury and acute respiratory distress syndrome.Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation.Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells.World Trade Center (WTC) dust exposure in mice is associated with inflammation, oxidative stress and epigenetic changes in the lung.In vitro effector activity of Pneumocystis murina-specific T-cytotoxic-1 CD8+ T cells: role of granulocyte-macrophage colony-stimulating factor.Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease.Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer.Pathological and protective immunity to Pneumocystis infection.Sensitized CD8+ T cells fail to control organism burden but accelerate the onset of lung injury during Pneumocystis carinii pneumonia.Sensitized splenocytes result in deleterious cytokine cascade and hyperinflammatory response in rats with Pneumocystis pneumonia despite the presence of corticosteroidsPneumocystis pneumonia increases the susceptibility of mice to sublethal hyperoxia.Pneumocystis murina MSG gene family and the structure of the locus associated with its transcriptionPneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in miceSurfactant dysfunction in lung contusion with and without superimposed gastric aspiration in a rat modelNeonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity.Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species.The Interaction of Pneumocystis with the C-Type Lectin Receptor Mincle Exerts a Significant Role in Host Defense against Infection.Immune reconstitution inflammatory syndrome associated with pulmonary pathogensIntravenous and intratracheal mesenchymal stromal cell injection in a mouse model of pulmonary emphysemaCharacterization of surfactant alterations in pigs infected with Actinobacillus pleuropneumoniae.Anti-CD3 antibody decreases inflammation and improves outcome in a murine model of Pneumocystis pneumonia.Pneumocystis carinii infection sensitizes lung to radiation-induced injury after syngeneic marrow transplantation: role of CD4+ T cells.Inhibition of surfactant activity by Pneumocystis carinii organisms and components in vitro.Survival after Pneumocystis jirovecii pneumonia requiring ventilation: A case report.Therapeutic efficacies of chitosan against Pneumocystis pneumonia of immunosuppressed rat.
P2860
Q28068836-58144BB1-42B3-4DE1-86BE-FCED06DFF5B8Q30409008-AAEEB3C4-EDB8-48E5-9C41-878E45885AEAQ30426177-D1F0D249-9519-4D7D-AF27-836AE585617FQ33593887-D1B2157F-EAD6-47C4-8662-2E6365201693Q33680480-E3DB41E0-3504-408B-9783-DC65B6A89E94Q33768874-6CBAAEFB-0701-4868-8822-5468D0B5D6E1Q33802584-79C238E2-40F2-48AF-A37F-526F34A2CCF2Q34111716-9411DD6A-ED89-4104-BD9D-3ADF3129311BQ34167435-5FE426EB-C10F-446F-9783-F4F0236B6316Q34331195-300D1D13-36DF-4E28-AB12-8D5BA5C33416Q35084980-677F009C-3BDB-4C0A-95E3-3912C550801CQ35217564-DCEA34FE-807A-4F84-8E5B-0CE33F04AFF8Q35550705-2BD6EBF3-4185-4BC9-BD39-9D1C04347D86Q36046306-13BE3D1C-DB74-4B8E-BECE-45325FD7955DQ36116575-8224C662-F6C8-4785-A48C-B084A2B495E4Q36804180-D9B14B02-5C0A-4865-83BA-37CDED88E969Q37216217-8E47542A-9F5B-4080-AAEE-D59B7C247EEEQ37406405-45FAF709-AD4C-427E-9252-73AF07294ED9Q37523896-8EA55AEB-7A82-4CC1-9521-14A20E32C3B1Q38905101-EBED3086-CC87-4CA7-A2BF-7B5115963736Q39065992-8812483F-EB9E-433E-B1C0-895BD8CB5A1AQ40354400-0D114FFD-161B-43BB-BAA9-D1721131AAB5Q40833788-F6BFB40B-D111-4696-8649-8FDD8821EABEQ42948319-439EF810-E8BF-4AC0-B443-E55F979AA83FQ47658527-80177679-91F5-45E4-A4CC-23AAB2C67696Q52564201-03D1917A-1BEE-4A27-BF3A-33A829D25C43Q53747576-4EACB0F8-8753-41E0-B6A6-B58ACA8FE147Q54214626-91787A68-8773-4139-A745-7301B3F23D35
P2860
Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pulmonary inflammation disrupt ...... neumocystis carinii pneumonia.
@ast
Pulmonary inflammation disrupt ...... neumocystis carinii pneumonia.
@en
Pulmonary inflammation disrupt ...... neumocystis carinii pneumonia.
@nl
type
label
Pulmonary inflammation disrupt ...... neumocystis carinii pneumonia.
@ast
Pulmonary inflammation disrupt ...... neumocystis carinii pneumonia.
@en
Pulmonary inflammation disrupt ...... neumocystis carinii pneumonia.
@nl
prefLabel
Pulmonary inflammation disrupt ...... neumocystis carinii pneumonia.
@ast
Pulmonary inflammation disrupt ...... neumocystis carinii pneumonia.
@en
Pulmonary inflammation disrupt ...... neumocystis carinii pneumonia.
@nl
P2093
P2860
P1476
Pulmonary inflammation disrupt ...... neumocystis carinii pneumonia.
@en
P2093
P2860
P304
P356
10.1128/IAI.69.2.758-764.2001
P407
P577
2001-02-01T00:00:00Z